Korea National Institute of Healthgrid.415482.e, Korea Disease Control and Prevention Agency, Cheongju-si, South Korea.
Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Microbiol Spectr. 2022 Aug 31;10(4):e0166022. doi: 10.1128/spectrum.01660-22. Epub 2022 Jul 7.
Escherichia coli is responsible for more than 80% of all incidences of urinary tract infections (UTIs). We assessed a total of 636 cases of patients with E. coli UTIs occurring in June 2019 in eight tertiary hospitals in South Korea for the traits of patients with E. coli UTIs, UTI-causative E. coli isolates, and risk factors associated with bloodstream infections (BSIs) secondary to UTIs. Antimicrobial susceptibility testing was conducted using the disc diffusion method, and the genes for extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated genes were screened by using PCR and sequencing. Multilocus sequence typing and virulence pheno-/genotyping were carried out. A total of 49 cases developed BSIs. The E. coli urine isolates primarily comprised sequence type 131 (ST131) (30.0%), followed by ST1193, ST95, ST73, and ST69. Three-quarters of the ST131 H30Rx isolates possessed the -like gene, whereas 66% of H30R and 50% of H41 isolates possessed the -like gene. All the ST1193 isolates showed biofilm formation ability, and three-quarters of the ST73 isolates exhibited hemolytic activity with high proportions of , , and positivity. The prevalence of the ST131 H41 sublineage and its abundant CTX-M possession among the E. coli urine isolates were noteworthy; however, no specific STs were associated with bloodstream invasion. For BSIs secondary to UTIs, the gene was likely identified as a UTI-causative E. coli-related risk factor and urogenital cancer (odds ratio [OR], 12.328), indwelling catheter (OR, 3.218), and costovertebral angle tenderness (OR, 2.779) were patient-related risk factors. Approximately half of the BSIs caused by E. coli are secondary to E. coli UTIs. Since the uropathogenic E. coli causing most of the UTIs is genetically diverse, understanding the risk factors in the E. coli urine isolates causing the BSI is important for pathophysiology. Although the UTIs are some of the most common bacterial infectious diseases, and the BSIs secondary to the UTIs are commonly caused by E. coli, the assessments to find the risk factors are mostly focused on the condition of patients, not on the bacterial pathogens. Molecular epidemiology of the UTI-causative E. coli pathogens, together with the characterization of the E. coli urine isolates associated with the BSI secondary to UTI, was carried out, suggesting treatment options for the prevalent antimicrobial-resistant organisms.
大肠埃希菌是引起 80%以上尿路感染(UTI)的主要病原体。我们评估了 2019 年 6 月韩国 8 家三级医院的 636 例大肠埃希菌 UTI 患者的特征、UTI 致病大肠埃希菌分离株以及与 UTI 相关的血流感染(BSI)的危险因素。采用纸片扩散法进行抗菌药物敏感性试验,通过 PCR 和测序筛选超广谱β-内酰胺酶(ESBLs)和质粒介导基因。进行多位点序列分型和毒力表型/基因型分析。共有 49 例发生 BSI。大肠埃希菌尿分离株主要由 ST131(30.0%)、ST1193、ST95、ST73 和 ST69 组成。75%的 ST131 H30Rx 分离株携带 blaCTX-M-15 基因,而 66%的 H30R 和 50%的 H41 分离株携带 blaCTX-M-14 基因。所有 ST1193 分离株均具有生物膜形成能力,75%的 ST73 分离株具有高比例的溶血活性和 、 和 阳性。大肠埃希菌尿分离株中 ST131 H41 亚系的流行和其丰富的 CTX-M 携带值得关注;然而,没有特定的 ST 与血流入侵相关。对于 UTI 相关的 BSI,blaCTX-M-15 基因可能被认为是 UTI 致病大肠埃希菌相关的危险因素,并且urogenital cancer(比值比[OR],12.328)、留置导尿管(OR,3.218)和肋脊角压痛(OR,2.779)是患者相关的危险因素。大约一半的大肠埃希菌引起的 BSI 继发于大肠埃希菌 UTI。由于引起大多数 UTI 的尿路致病性大肠埃希菌具有遗传多样性,了解引起 BSI 的大肠埃希菌尿分离株的危险因素对于了解发病机制很重要。虽然 UTI 是最常见的细菌性传染病之一,UTI 相关的 BSI 通常由大肠埃希菌引起,但寻找危险因素的评估主要集中在患者的病情上,而不是细菌病原体上。对 UTI 致病大肠埃希菌病原体进行分子流行病学研究,并对与 UTI 相关的 BSI 相关的大肠埃希菌尿分离株进行特征分析,为治疗常见的耐药菌提供了选择。